279 related articles for article (PubMed ID: 26237765)
21. CD98 is a promising prognostic biomarker in biliary tract cancer.
Kaira K; Sunose Y; Oriuchi N; Kanai Y; Takeyoshi I
Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):654-7. PubMed ID: 25475870
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis.
Zhang C; Xu J; Xue S; Ye J
Mol Diagn Ther; 2020 Oct; 24(5):523-536. PubMed ID: 32410110
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Br J Cancer; 2008 Feb; 98(4):742-8. PubMed ID: 18253116
[TBL] [Abstract][Full Text] [Related]
24. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
Imai H; Kaira K; Oriuchi N; Shimizu K; Tominaga H; Yanagitani N; Sunaga N; Ishizuka T; Nagamori S; Promchan K; Nakajima T; Yamamoto N; Mori M; Kanai Y
Anticancer Res; 2010 Dec; 30(12):4819-28. PubMed ID: 21187458
[TBL] [Abstract][Full Text] [Related]
26. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
27. Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma.
Isoda A; Kaira K; Iwashina M; Oriuchi N; Tominaga H; Nagamori S; Kanai Y; Oyama T; Asao T; Matsumoto M; Sawamura M
Cancer Sci; 2014 Nov; 105(11):1496-502. PubMed ID: 25220100
[TBL] [Abstract][Full Text] [Related]
28. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma.
Nikkuni O; Kaira K; Toyoda M; Shino M; Sakakura K; Takahashi K; Tominaga H; Oriuchi N; Suzuki M; Iijima M; Asao T; Nishiyama M; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
Pathol Oncol Res; 2015 Sep; 21(4):1175-81. PubMed ID: 26024742
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.
Kaira K; Nakamura K; Hirakawa T; Imai H; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Tsukamoto N; Oyama T; Asao T; Minegishi T
Am J Transl Res; 2015; 7(6):1161-71. PubMed ID: 26279759
[TBL] [Abstract][Full Text] [Related]
30. L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.
Yanagisawa N; Satoh T; Hana K; Ichinoe M; Nakada N; Endou H; Okayasu I; Murakumo Y
Cancer Biomark; 2015; 15(4):365-74. PubMed ID: 25835180
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of class III β-tubulin is associated with unfavourable prognosis in patients with malignant melanoma.
Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
Melanoma Res; 2016 Feb; 26(1):29-34. PubMed ID: 26426765
[TBL] [Abstract][Full Text] [Related]
33. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas.
Yanagisawa N; Ichinoe M; Mikami T; Nakada N; Hana K; Koizumi W; Endou H; Okayasu I
J Clin Pathol; 2012 Nov; 65(11):1019-23. PubMed ID: 22813728
[TBL] [Abstract][Full Text] [Related]
34. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
35. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
36. Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
Namikawa M; Kakizaki S; Kaira K; Tojima H; Yamazaki Y; Horiguchi N; Sato K; Oriuchi N; Tominaga H; Sunose Y; Nagamori S; Kanai Y; Oyama T; Takeyoshi I; Yamada M
Hepatol Res; 2015 Sep; 45(9):1014-1022. PubMed ID: 25297701
[TBL] [Abstract][Full Text] [Related]
37. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
38. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer.
Sakata T; Ferdous G; Tsuruta T; Satoh T; Baba S; Muto T; Ueno A; Kanai Y; Endou H; Okayasu I
Pathol Int; 2009 Jan; 59(1):7-18. PubMed ID: 19121087
[TBL] [Abstract][Full Text] [Related]
39. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Exp Ther Med; 2010 Sep; 1(5):799-808. PubMed ID: 22993604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
